APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brucella Abortus Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Brucella Abortus Vaccine Industry Research Report 2026

20 December 2025146 pages

Choose your research edition.

Industry ResearchBrucella Abortus Vaccine Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Brucella Abortus Vaccine Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Brucella Abortus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brucella Abortus Vaccine Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Brucella Abortus Vaccine Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Brucella Abortus Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Brucella Abortus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Brucella Abortus Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Brucella Abortus Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Brucella Abortus Vaccine include Zoetis, Qilu Animal Health, Merck Animal Health, Vetal, VECOL, Tecnovax, SYVA Laboratorios, Onderstepoort Biological Products and Merial, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Brucella Abortus Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Brucella Abortus Vaccine Market by Company

Zoetis

Qilu Animal Health

Merck Animal Health

Vetal

VECOL

Tecnovax

SYVA Laboratorios

Onderstepoort Biological Products

Merial

JOVAC

Instituto Rosenbusch

Institute of Animal Health and Veterinary Biologicals

Indian Immunologicals

Hester Biosciences

Dollvet

CZ Veterinaria

Colorado Serum Company

CEVA

Centro Diagnostico Veterinario

CAVAC

Biovet

Biogenesis Bago

Brucella Abortus Vaccine Segment by Type

Vector Vaccines

Subunit Vaccines

DNA Vaccines

B. Abortus Recombinant Mutants

Others

Brucella Abortus Vaccine Segment by Application

Pigs

Sheep

Cattles

Others

Brucella Abortus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucella Abortus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brucella Abortus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucella Abortus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Brucella Abortus Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Brucella Abortus Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Brucella Abortus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Brucella Abortus Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Brucella Abortus Vaccine Sales (k units) of Manufacturers (2021-2026) Table 7. Global Brucella Abortus Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Brucella Abortus Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Brucella Abortus Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Brucella Abortus Vaccine Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Brucella Abortus Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Brucella Abortus Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Brucella Abortus Vaccine, Product Type & Application Table 14. Global Brucella Abortus Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Brucella Abortus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zoetis Company Information Table 19. Zoetis Business Overview Table 20. Zoetis Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Zoetis Brucella Abortus Vaccine Product Portfolio Table 22. Zoetis Recent Developments Table 23. Qilu Animal Health Company Information Table 24. Qilu Animal Health Business Overview Table 25. Qilu Animal Health Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Qilu Animal Health Brucella Abortus Vaccine Product Portfolio Table 27. Qilu Animal Health Recent Developments Table 28. Merck Animal Health Company Information Table 29. Merck Animal Health Business Overview Table 30. Merck Animal Health Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Merck Animal Health Brucella Abortus Vaccine Product Portfolio Table 32. Merck Animal Health Recent Developments Table 33. Vetal Company Information Table 34. Vetal Business Overview Table 35. Vetal Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Vetal Brucella Abortus Vaccine Product Portfolio Table 37. Vetal Recent Developments Table 38. VECOL Company Information Table 39. VECOL Business Overview Table 40. VECOL Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. VECOL Brucella Abortus Vaccine Product Portfolio Table 42. VECOL Recent Developments Table 43. Tecnovax Company Information Table 44. Tecnovax Business Overview Table 45. Tecnovax Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Tecnovax Brucella Abortus Vaccine Product Portfolio Table 47. Tecnovax Recent Developments Table 48. SYVA Laboratorios Company Information Table 49. SYVA Laboratorios Business Overview Table 50. SYVA Laboratorios Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. SYVA Laboratorios Brucella Abortus Vaccine Product Portfolio Table 52. SYVA Laboratorios Recent Developments Table 53. Onderstepoort Biological Products Company Information Table 54. Onderstepoort Biological Products Business Overview Table 55. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Onderstepoort Biological Products Brucella Abortus Vaccine Product Portfolio Table 57. Onderstepoort Biological Products Recent Developments Table 58. Merial Company Information Table 59. Merial Business Overview Table 60. Merial Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Merial Brucella Abortus Vaccine Product Portfolio Table 62. Merial Recent Developments Table 63. JOVAC Company Information Table 64. JOVAC Business Overview Table 65. JOVAC Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. JOVAC Brucella Abortus Vaccine Product Portfolio Table 67. JOVAC Recent Developments Table 68. Instituto Rosenbusch Company Information Table 69. Instituto Rosenbusch Business Overview Table 70. Instituto Rosenbusch Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Instituto Rosenbusch Brucella Abortus Vaccine Product Portfolio Table 72. Instituto Rosenbusch Recent Developments Table 73. Institute of Animal Health and Veterinary Biologicals Company Information Table 74. Institute of Animal Health and Veterinary Biologicals Business Overview Table 75. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Portfolio Table 77. Institute of Animal Health and Veterinary Biologicals Recent Developments Table 78. Indian Immunologicals Company Information Table 79. Indian Immunologicals Business Overview Table 80. Indian Immunologicals Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Indian Immunologicals Brucella Abortus Vaccine Product Portfolio Table 82. Indian Immunologicals Recent Developments Table 83. Hester Biosciences Company Information Table 84. Hester Biosciences Business Overview Table 85. Hester Biosciences Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Hester Biosciences Brucella Abortus Vaccine Product Portfolio Table 87. Hester Biosciences Recent Developments Table 88. Dollvet Company Information Table 89. Dollvet Business Overview Table 90. Dollvet Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Dollvet Brucella Abortus Vaccine Product Portfolio Table 92. Dollvet Recent Developments Table 93. CZ Veterinaria Company Information Table 94. CZ Veterinaria Business Overview Table 95. CZ Veterinaria Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. CZ Veterinaria Brucella Abortus Vaccine Product Portfolio Table 97. CZ Veterinaria Recent Developments Table 98. Colorado Serum Company Company Information Table 99. Colorado Serum Company Business Overview Table 100. Colorado Serum Company Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Colorado Serum Company Brucella Abortus Vaccine Product Portfolio Table 102. Colorado Serum Company Recent Developments Table 103. CEVA Company Information Table 104. CEVA Business Overview Table 105. CEVA Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. CEVA Brucella Abortus Vaccine Product Portfolio Table 107. CEVA Recent Developments Table 108. Centro Diagnostico Veterinario Company Information Table 109. Centro Diagnostico Veterinario Business Overview Table 110. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Portfolio Table 112. Centro Diagnostico Veterinario Recent Developments Table 113. CAVAC Company Information Table 114. CAVAC Business Overview Table 115. CAVAC Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. CAVAC Brucella Abortus Vaccine Product Portfolio Table 117. CAVAC Recent Developments Table 118. Biovet Company Information Table 119. Biovet Business Overview Table 120. Biovet Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Biovet Brucella Abortus Vaccine Product Portfolio Table 122. Biovet Recent Developments Table 123. Biogenesis Bago Company Information Table 124. Biogenesis Bago Business Overview Table 125. Biogenesis Bago Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Biogenesis Bago Brucella Abortus Vaccine Product Portfolio Table 127. Biogenesis Bago Recent Developments Table 128. Global Brucella Abortus Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 129. Global Brucella Abortus Vaccine Sales by Region (2021-2026) & (k units) Table 130. Global Brucella Abortus Vaccine Sales Market Share by Region (2021-2026) Table 131. Global Brucella Abortus Vaccine Sales by Region (2027-2032) & (k units) Table 132. Global Brucella Abortus Vaccine Sales Market Share by Region (2027-2032) Table 133. Global Brucella Abortus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 134. Global Brucella Abortus Vaccine Revenue Market Share by Region (2021-2026) Table 135. Global Brucella Abortus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 136. Global Brucella Abortus Vaccine Revenue Market Share by Region (2027-2032) Table 137. North America Brucella Abortus Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. North America Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 139. North America Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 140. North America Brucella Abortus Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Brucella Abortus Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 142. Europe Brucella Abortus Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Europe Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 144. Europe Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 145. Europe Brucella Abortus Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 146. Europe Brucella Abortus Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 147. Asia Pacific Brucella Abortus Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Asia Pacific Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 149. Asia Pacific Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 150. Asia Pacific Brucella Abortus Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 151. Asia Pacific Brucella Abortus Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 152. South America Brucella Abortus Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. South America Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 154. South America Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 155. South America Brucella Abortus Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 156. South America Brucella Abortus Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Brucella Abortus Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Middle East and Africa Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 159. Middle East and Africa Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 160. Middle East and Africa Brucella Abortus Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Brucella Abortus Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 162. Global Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 163. Global Brucella Abortus Vaccine Sales by Type (2027-2032) & (k units) Table 164. Global Brucella Abortus Vaccine Sales Market Share by Type (2021-2026) Table 165. Global Brucella Abortus Vaccine Sales Market Share by Type (2027-2032) Table 166. Global Brucella Abortus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 167. Global Brucella Abortus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 168. Global Brucella Abortus Vaccine Revenue Market Share by Type (2021-2026) Table 169. Global Brucella Abortus Vaccine Revenue Market Share by Type (2027-2032) Table 170. Global Brucella Abortus Vaccine Price by Type (2021-2026) & (US$/unit) Table 171. Global Brucella Abortus Vaccine Price by Type (2027-2032) & (US$/unit) Table 172. Global Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 173. Global Brucella Abortus Vaccine Sales by Application (2027-2032) & (k units) Table 174. Global Brucella Abortus Vaccine Sales Market Share by Application (2021-2026) Table 175. Global Brucella Abortus Vaccine Sales Market Share by Application (2027-2032) Table 176. Global Brucella Abortus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 177. Global Brucella Abortus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 178. Global Brucella Abortus Vaccine Revenue Market Share by Application (2021-2026) Table 179. Global Brucella Abortus Vaccine Revenue Market Share by Application (2027-2032) Table 180. Global Brucella Abortus Vaccine Price by Application (2021-2026) & (US$/unit) Table 181. Global Brucella Abortus Vaccine Price by Application (2027-2032) & (US$/unit) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Brucella Abortus Vaccine Distributors List Table 185. Brucella Abortus Vaccine Customers List Table 186. Brucella Abortus Vaccine Industry Trends Table 187. Brucella Abortus Vaccine Industry Drivers Table 188. Brucella Abortus Vaccine Industry Restraints Table 189. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Brucella Abortus Vaccine Product Image Figure 5. Global Brucella Abortus Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Brucella Abortus Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Brucella Abortus Vaccine Sales (2021-2032) & (k units) Figure 8. Global Brucella Abortus Vaccine Average Price (US$/unit) & (2021-2032) Figure 9. Vector Vaccines Product Image Figure 10. Subunit Vaccines Product Image Figure 11. DNA Vaccines Product Image Figure 12. B. Abortus Recombinant Mutants Product Image Figure 13. Others Product Image Figure 14. Pigs Product Image Figure 15. Sheep Product Image Figure 16. Cattles Product Image Figure 17. Others Product Image Figure 18. Global Brucella Abortus Vaccine Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Brucella Abortus Vaccine, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Brucella Abortus Vaccine Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Brucella Abortus Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Brucella Abortus Vaccine Sales by Region in 2025 Figure 24. Global Brucella Abortus Vaccine Revenue by Region in 2025 Figure 25. North America Brucella Abortus Vaccine Market Size by Country in 2025 Figure 26. North America Brucella Abortus Vaccine Sales Market Share by Country (2021-2032) Figure 27. North America Brucella Abortus Vaccine Revenue Market Share by Country (2021-2032) Figure 28. United States Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Mexico Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Brucella Abortus Vaccine Market Size by Country in 2025 Figure 32. Europe Brucella Abortus Vaccine Sales Market Share by Country (2021-2032) Figure 33. Europe Brucella Abortus Vaccine Revenue Market Share by Country (2021-2032) Figure 34. Germany Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Russia Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Spain Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Switzerland Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Sweden Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Poland Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Asia Pacific Brucella Abortus Vaccine Market Size by Country in 2025 Figure 45. Asia Pacific Brucella Abortus Vaccine Sales Market Share by Country (2021-2032) Figure 46. Asia Pacific Brucella Abortus Vaccine Revenue Market Share by Country (2021-2032) Figure 47. China Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Japan Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South Korea Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. India Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Australia Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Taiwan Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. South America Brucella Abortus Vaccine Market Size by Country in 2025 Figure 56. South America Brucella Abortus Vaccine Sales Market Share by Country (2021-2032) Figure 57. South America Brucella Abortus Vaccine Revenue Market Share by Country (2021-2032) Figure 58. Brazil Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Argentina Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Chile Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Colombia Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Middle East and Africa Brucella Abortus Vaccine Market Size by Country in 2025 Figure 63. Middle East and Africa Brucella Abortus Vaccine Sales Market Share by Country (2021-2032) Figure 64. Middle East and Africa Brucella Abortus Vaccine Revenue Market Share by Country (2021-2032) Figure 65. Egypt Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. South Africa Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Israel Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Türkiye Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. GCC Countries Brucella Abortus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Global Brucella Abortus Vaccine Sales Market Share by Type (2021-2032) Figure 71. Global Brucella Abortus Vaccine Revenue Market Share by Type (2021-2032) Figure 72. Global Brucella Abortus Vaccine Price (US$/unit) by Type (2021-2032) Figure 73. Global Brucella Abortus Vaccine Sales Market Share by Application (2021-2032) Figure 74. Global Brucella Abortus Vaccine Revenue Market Share by Application (2021-2032) Figure 75. Global Brucella Abortus Vaccine Price (US$/unit) by Application (2021-2032) Figure 76. Brucella Abortus Vaccine Value Chain Figure 77. Brucella Abortus Vaccine Production Mode & Process Figure 78. Direct Comparison with Distribution Share Figure 79. Distributors Profiles Figure 80. Brucella Abortus Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Vector Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • B. Abortus Recombinant Mutants
  • Others
Applications
  • Pigs
  • Sheep
  • Cattles
  • Others
Companies covered
  • Zoetis
  • Qilu Animal Health
  • Merck Animal Health
  • Vetal
  • VECOL
  • Tecnovax
  • SYVA Laboratorios
  • Onderstepoort Biological Products
  • Merial
  • JOVAC
  • Instituto Rosenbusch
  • Institute of Animal Health and Veterinary Biologicals
  • Indian Immunologicals
  • Hester Biosciences
  • Dollvet
  • CZ Veterinaria
  • Colorado Serum Company
  • CEVA
  • Centro Diagnostico Veterinario
  • CAVAC
  • Biovet
  • Biogenesis Bago

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Brucella Abortus Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Brucella Abortus Vaccine Sales (2021-2032)
  5. 2.2.3 Global Brucella Abortus Vaccine Market Average Price (2021-2032)
  6. 2.3 Brucella Abortus Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Vector Vaccines
  9. 2.3.3 Subunit Vaccines
  10. 2.3.4 DNA Vaccines
  11. 2.3.5 B. Abortus Recombinant Mutants
  12. 2.3.6 Others
  13. 2.4 Brucella Abortus Vaccine by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Pigs
  16. 2.4.3 Sheep
  17. 2.4.4 Cattles
  18. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Brucella Abortus Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Brucella Abortus Vaccine Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Brucella Abortus Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Brucella Abortus Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Brucella Abortus Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Brucella Abortus Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Brucella Abortus Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Brucella Abortus Vaccine, Established Date
  9. 3.9 Global Brucella Abortus Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zoetis
  2. 4.1.1 Zoetis Company Information
  3. 4.1.2 Zoetis Business Overview
  4. 4.1.3 Zoetis Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zoetis Brucella Abortus Vaccine Product Portfolio
  6. 4.1.5 Zoetis Recent Developments
  7. 4.2 Qilu Animal Health
  8. 4.2.1 Qilu Animal Health Company Information
  9. 4.2.2 Qilu Animal Health Business Overview
  10. 4.2.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Qilu Animal Health Brucella Abortus Vaccine Product Portfolio
  12. 4.2.5 Qilu Animal Health Recent Developments
  13. 4.3 Merck Animal Health
  14. 4.3.1 Merck Animal Health Company Information
  15. 4.3.2 Merck Animal Health Business Overview
  16. 4.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Merck Animal Health Brucella Abortus Vaccine Product Portfolio
  18. 4.3.5 Merck Animal Health Recent Developments
  19. 4.4 Vetal
  20. 4.4.1 Vetal Company Information
  21. 4.4.2 Vetal Business Overview
  22. 4.4.3 Vetal Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Vetal Brucella Abortus Vaccine Product Portfolio
  24. 4.4.5 Vetal Recent Developments
  25. 4.5 VECOL
  26. 4.5.1 VECOL Company Information
  27. 4.5.2 VECOL Business Overview
  28. 4.5.3 VECOL Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 VECOL Brucella Abortus Vaccine Product Portfolio
  30. 4.5.5 VECOL Recent Developments
  31. 4.6 Tecnovax
  32. 4.6.1 Tecnovax Company Information
  33. 4.6.2 Tecnovax Business Overview
  34. 4.6.3 Tecnovax Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Tecnovax Brucella Abortus Vaccine Product Portfolio
  36. 4.6.5 Tecnovax Recent Developments
  37. 4.7 SYVA Laboratorios
  38. 4.7.1 SYVA Laboratorios Company Information
  39. 4.7.2 SYVA Laboratorios Business Overview
  40. 4.7.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 SYVA Laboratorios Brucella Abortus Vaccine Product Portfolio
  42. 4.7.5 SYVA Laboratorios Recent Developments
  43. 4.8 Onderstepoort Biological Products
  44. 4.8.1 Onderstepoort Biological Products Company Information
  45. 4.8.2 Onderstepoort Biological Products Business Overview
  46. 4.8.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Onderstepoort Biological Products Brucella Abortus Vaccine Product Portfolio
  48. 4.8.5 Onderstepoort Biological Products Recent Developments
  49. 4.9 Merial
  50. 4.9.1 Merial Company Information
  51. 4.9.2 Merial Business Overview
  52. 4.9.3 Merial Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Merial Brucella Abortus Vaccine Product Portfolio
  54. 4.9.5 Merial Recent Developments
  55. 4.10 JOVAC
  56. 4.10.1 JOVAC Company Information
  57. 4.10.2 JOVAC Business Overview
  58. 4.10.3 JOVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 JOVAC Brucella Abortus Vaccine Product Portfolio
  60. 4.10.5 JOVAC Recent Developments
  61. 4.11 Instituto Rosenbusch
  62. 4.11.1 Instituto Rosenbusch Company Information
  63. 4.11.2 Instituto Rosenbusch Business Overview
  64. 4.11.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Instituto Rosenbusch Brucella Abortus Vaccine Product Portfolio
  66. 4.11.5 Instituto Rosenbusch Recent Developments
  67. 4.12 Institute of Animal Health and Veterinary Biologicals
  68. 4.12.1 Institute of Animal Health and Veterinary Biologicals Company Information
  69. 4.12.2 Institute of Animal Health and Veterinary Biologicals Business Overview
  70. 4.12.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Portfolio
  72. 4.12.5 Institute of Animal Health and Veterinary Biologicals Recent Developments
  73. 4.13 Indian Immunologicals
  74. 4.13.1 Indian Immunologicals Company Information
  75. 4.13.2 Indian Immunologicals Business Overview
  76. 4.13.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Indian Immunologicals Brucella Abortus Vaccine Product Portfolio
  78. 4.13.5 Indian Immunologicals Recent Developments
  79. 4.14 Hester Biosciences
  80. 4.14.1 Hester Biosciences Company Information
  81. 4.14.2 Hester Biosciences Business Overview
  82. 4.14.3 Hester Biosciences Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Hester Biosciences Brucella Abortus Vaccine Product Portfolio
  84. 4.14.5 Hester Biosciences Recent Developments
  85. 4.15 Dollvet
  86. 4.15.1 Dollvet Company Information
  87. 4.15.2 Dollvet Business Overview
  88. 4.15.3 Dollvet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Dollvet Brucella Abortus Vaccine Product Portfolio
  90. 4.15.5 Dollvet Recent Developments
  91. 4.16 CZ Veterinaria
  92. 4.16.1 CZ Veterinaria Company Information
  93. 4.16.2 CZ Veterinaria Business Overview
  94. 4.16.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 CZ Veterinaria Brucella Abortus Vaccine Product Portfolio
  96. 4.16.5 CZ Veterinaria Recent Developments
  97. 4.17 Colorado Serum Company
  98. 4.17.1 Colorado Serum Company Company Information
  99. 4.17.2 Colorado Serum Company Business Overview
  100. 4.17.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Colorado Serum Company Brucella Abortus Vaccine Product Portfolio
  102. 4.17.5 Colorado Serum Company Recent Developments
  103. 4.18 CEVA
  104. 4.18.1 CEVA Company Information
  105. 4.18.2 CEVA Business Overview
  106. 4.18.3 CEVA Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 CEVA Brucella Abortus Vaccine Product Portfolio
  108. 4.18.5 CEVA Recent Developments
  109. 4.19 Centro Diagnostico Veterinario
  110. 4.19.1 Centro Diagnostico Veterinario Company Information
  111. 4.19.2 Centro Diagnostico Veterinario Business Overview
  112. 4.19.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Portfolio
  114. 4.19.5 Centro Diagnostico Veterinario Recent Developments
  115. 4.20 CAVAC
  116. 4.20.1 CAVAC Company Information
  117. 4.20.2 CAVAC Business Overview
  118. 4.20.3 CAVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 CAVAC Brucella Abortus Vaccine Product Portfolio
  120. 4.20.5 CAVAC Recent Developments
  121. 4.21 Biovet
  122. 4.21.1 Biovet Company Information
  123. 4.21.2 Biovet Business Overview
  124. 4.21.3 Biovet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Biovet Brucella Abortus Vaccine Product Portfolio
  126. 4.21.5 Biovet Recent Developments
  127. 4.22 Biogenesis Bago
  128. 4.22.1 Biogenesis Bago Company Information
  129. 4.22.2 Biogenesis Bago Business Overview
  130. 4.22.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Biogenesis Bago Brucella Abortus Vaccine Product Portfolio
  132. 4.22.5 Biogenesis Bago Recent Developments
5 Global Brucella Abortus Vaccine Market Scenario by Region
  1. 5.1 Global Brucella Abortus Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Brucella Abortus Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Brucella Abortus Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Brucella Abortus Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Brucella Abortus Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Brucella Abortus Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Brucella Abortus Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Brucella Abortus Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Brucella Abortus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Brucella Abortus Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Brucella Abortus Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Brucella Abortus Vaccine Market Facts & Figures by Country
  16. 5.5.1 Europe Brucella Abortus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Brucella Abortus Vaccine Sales by Country (2021-2032)
  18. 5.5.3 Europe Brucella Abortus Vaccine Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Brucella Abortus Vaccine Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Brucella Abortus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Brucella Abortus Vaccine Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Brucella Abortus Vaccine Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Brucella Abortus Vaccine Market Facts & Figures by Country
  41. 5.7.1 South America Brucella Abortus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Brucella Abortus Vaccine Sales by Country (2021-2032)
  43. 5.7.3 South America Brucella Abortus Vaccine Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Brucella Abortus Vaccine Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Brucella Abortus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Brucella Abortus Vaccine Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Brucella Abortus Vaccine Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Brucella Abortus Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Brucella Abortus Vaccine Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Brucella Abortus Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Brucella Abortus Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Brucella Abortus Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Brucella Abortus Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Brucella Abortus Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Brucella Abortus Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Brucella Abortus Vaccine Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Brucella Abortus Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Brucella Abortus Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Brucella Abortus Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Brucella Abortus Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Brucella Abortus Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Brucella Abortus Vaccine Value Chain Analysis
  2. 8.1.1 Brucella Abortus Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Brucella Abortus Vaccine Production Mode & Process
  5. 8.2 Brucella Abortus Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Brucella Abortus Vaccine Distributors
  8. 8.2.3 Brucella Abortus Vaccine Customers
9 Global Brucella Abortus Vaccine Analyzing Market Dynamics
  1. 9.1 Brucella Abortus Vaccine Industry Trends
  2. 9.2 Brucella Abortus Vaccine Industry Drivers
  3. 9.3 Brucella Abortus Vaccine Industry Opportunities and Challenges
  4. 9.4 Brucella Abortus Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst